Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Prosperini

Showing results (51-60 of 182) with videos related to

Pageof 19
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 9, 2026
First pediatric migraine with transient hypoperfusion, venous abnormalities and EEG slowingLuca Prosperini, Margherita Federici, Alessandro Stasolla, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 11, 2019
Dalfampridine to Improve Balance in Multiple Sclerosis: Substudy from a Randomized Placebo-Controlled TrialLuca Prosperini, Letizia Castelli, Laura De Giglio, et al.
Therapeutic Advances in Neurological Disorders|May 26, 2021
Dalfampridine improves slowed processing speed in multiple sclerosis patients with mild motor disability: post hoc analysis of a randomized controlled trialCarlo Pozzilli, Luca Prosperini, Silvia Tommasin, et al.
Journal of Neurovirology|August 10, 2017
Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathyLuca Prosperini, Cristina Scarpazza, Luisa Imberti, et al.
Expert Opinion on Emerging Drugs|September 4, 2008
Emerging oral drugs for multiple sclerosisClaudio Gasperini, Luca Ausili Cefaro, Giovanna Borriello, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 31, 2012
Determinants of the severity of comorbid migraine in multiple sclerosisVeronica Villani, Laura De Giglio, Giuliano Sette, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 18, 2023
Brain and cognitive reserve mitigate balance dysfunction in multiple sclerosisLuca Prosperini, Irene Alcamisi, Maria Esmeralda Quartuccio, et al.
Headache|April 11, 2012
The impact of interferon beta and natalizumab on comorbid migraine in multiple sclerosisVeronica Villani, Luca Prosperini, Laura De Giglio, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 6, 2016
The dual task-cost of standing balance affects quality of life in mildly disabled MS peopleLetizia Castelli, Francesca De Luca, Maria Rita Marchetti, et al.
Journal of the Neurological Sciences|September 26, 2012
Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosisLuca Prosperini, Costanza Giannì, Valeria Barletta, et al.
Pageof 19

Showing results (51-60 of 182) with videos related to

Sort By:
Pageof 19
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 9, 2026
First pediatric migraine with transient hypoperfusion, venous abnormalities and EEG slowingLuca Prosperini, Margherita Federici, Alessandro Stasolla, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 11, 2019
Dalfampridine to Improve Balance in Multiple Sclerosis: Substudy from a Randomized Placebo-Controlled TrialLuca Prosperini, Letizia Castelli, Laura De Giglio, et al.
Therapeutic Advances in Neurological Disorders|May 26, 2021
Dalfampridine improves slowed processing speed in multiple sclerosis patients with mild motor disability: post hoc analysis of a randomized controlled trialCarlo Pozzilli, Luca Prosperini, Silvia Tommasin, et al.
Journal of Neurovirology|August 10, 2017
Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathyLuca Prosperini, Cristina Scarpazza, Luisa Imberti, et al.
Expert Opinion on Emerging Drugs|September 4, 2008
Emerging oral drugs for multiple sclerosisClaudio Gasperini, Luca Ausili Cefaro, Giovanna Borriello, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 31, 2012
Determinants of the severity of comorbid migraine in multiple sclerosisVeronica Villani, Laura De Giglio, Giuliano Sette, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 18, 2023
Brain and cognitive reserve mitigate balance dysfunction in multiple sclerosisLuca Prosperini, Irene Alcamisi, Maria Esmeralda Quartuccio, et al.
Headache|April 11, 2012
The impact of interferon beta and natalizumab on comorbid migraine in multiple sclerosisVeronica Villani, Luca Prosperini, Laura De Giglio, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 6, 2016
The dual task-cost of standing balance affects quality of life in mildly disabled MS peopleLetizia Castelli, Francesca De Luca, Maria Rita Marchetti, et al.
Journal of the Neurological Sciences|September 26, 2012
Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosisLuca Prosperini, Costanza Giannì, Valeria Barletta, et al.
Pageof 19